Specialty Medicines Sales Rep — Remote/Hybrid

Amgen Inc.; United States; Híbrido; USD 90.000 - 122.000; Tempo integral

Benefícios oferecidos por esta vaga

Retirement and Savings Plan

Stock-based long-term incentives

Health and welfare benefits

Flexible work models

Resumo da vaga

Amgen Inc. is seeking a Specialty Representative to act as the primary customer contact for demand creation and to promote Amgen products within a defined sales territory.

You will execute marketing strategies, deliver branded messages, and coordinate medical education programs to drive sales. As a sales leader, you will develop territory plans with the District Manager, service accounts, ensure product access, and resolve reimbursement issues.

Qualificações

• Bachelor's degree required or higher.
• Alternate paths: an associate's degree with 4+ years in sales/clinical field.
• High school diploma/GED with 6+ years in sales/clinical field.

Responsabilidades

• Serve as the primary customer contact for demand creation by executing marketing strategy and promoting Amgen products.
• Achieve territory sales targets by executing Plans of Action and delivering branded messages and programs.
• Manage accounts, ensure product access, and resolve reimbursement issues.
• Provide feedback on marketing strategy and develop territory plans with the District Manager.

Conhecimentos

Sales planning

Communication

Relationship building

Negotiation

Strategic selling

Formação

Bachelor's degree

Associate's degree + 4 years sales/clinical experience

High school diploma + 6 years sales/clinical experience

Descrição da vaga

Amgen Inc. is seeking a Specialty Representative to act as the primary customer contact for demand creation and to promote Amgen products within a defined sales territory.

You will execute marketing strategies, deliver branded messages, and coordinate medical education programs to drive sales. As a sales leader, you will develop territory plans with the District Manager, service accounts, ensure product access, and resolve reimbursement issues.